1-(3-c-ethynylribopentofuranosyl)uracil has been researched along with temozolomide in 1 studies
| Studies (1-(3-c-ethynylribopentofuranosyl)uracil) | Trials (1-(3-c-ethynylribopentofuranosyl)uracil) | Recent Studies (post-2010) (1-(3-c-ethynylribopentofuranosyl)uracil) | Studies (temozolomide) | Trials (temozolomide) | Recent Studies (post-2010) (temozolomide) |
|---|---|---|---|---|---|
| 11 | 0 | 2 | 6,014 | 826 | 4,331 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, H; Echizenya, S; Fujii, Y; Ichikawa, S; Isogawa, M; Kondo, T; Maenaka, K; Matsuda, A; Natsumeda, M; Ogura, R; Ohtsu, N; Otsuguro, S; Sakaitani, M; Tsukamoto, Y | 1 |
1 other study(ies) available for 1-(3-c-ethynylribopentofuranosyl)uracil and temozolomide
| Article | Year |
|---|---|
Chemical Screening Identifies EUrd as a Novel Inhibitor Against Temozolomide-Resistant Glioblastoma-Initiating Cells.
Topics: 5'-Nucleotidase; Animals; Brain Neoplasms; Carcinogenesis; Cell Cycle Checkpoints; Cell Death; Cell Line, Tumor; Dacarbazine; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Glioblastoma; Glycoproteins; Humans; Mice, SCID; Temozolomide; Uracil; Uridine | 2016 |